We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
For this year’s digital event, BioPharm America will focus on innovation and investing, with the added collaboration of a number of diverse partners, whose unique offerings include live and recorded panel discussions, workshops and fireside chats.
OCT Clinical will be represented by Anna Lineva, Business Development Manager. Book a meeting with OCT team to discuss your clinical trial options at alineva@oct-clinicaltrials.com
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.